post first quarter expect
page full analyst note may
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim feb
price data jun
rate updat jun
currenc amount express
valuat growth profit
methodolog valu compani
domin dialysi market make compani
standout provid health servic industri like
manag recent decis sell medic group segment
formerli healthcar partner creat littl sharehold
valu oper risk reimburs pressur
divis caus under-perform manag intend use
larg portion billion sale proce reduc debt
buy back share howev acquisit like remain card
creat reason skeptic given recent track
record regardless anticip return capit
improv firm reinvest core dialysi oper
remain foundat compani econom moat
sever measur includ same-facil treatment growth
abil off-set reimburs pressur intern cost
control exceed expect dialysi
busi strong oper execut -- combin age
popul rise diabet rate obes epidem
intern expans opportun -- sustain healthi
demand perform also earli stage build
intern dialysi footprint
despit attract patient volum growth opportun
reimburs challeng continu weigh
earn reimburs tie quality-of-car metric slow
medicar growth healthcar reform past chang
dialysi bundl reflect diminish drug util
subdu payment growth littl relief sight patient cover
medicar medicaid account nearli
treatment revenu margin patient
razor-thin commerci rate remain healthier despit
recent pushback premium assist program regardless
thank law requir month dialysi
payment commerci payer medicar take
primari payer littl opportun exist expand
contribut profit patient make
compani report profit
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
world second-largest dialysi provid
clinic base compani treat nearli patient
end-stag renal diseas compani clinic market
outsid recent decid sell medic group
busi -- origin acquir name healthcar
partner -- billion
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
post first quarter expect
dont anticip chang fair valu estim
compani first-quart result mostli
match expect manag year-end outlook
remain unchang appear achiev thank
mostli stabl perform dialysi oper
still anticip sale medic group segment formerli
healthcar partner close year view sale
posit firm narrow econom moat thank
reimburs pressur limit competit advantag
busi still anticip larg portion
sale proce util share repurchas
treatment growth
oper margin quarter align
reimburs pressur
account chang alreadi anticip margin
pressur year adjust oper margin
basi point year-ago period
rise labor cost remain concern industri
manag held total cost per treatment growth
increas revenu per treatment
manag note mostli neutral effect medicar
part reimburs calcimimet parsabiv versu
previou payment drug paid part
seem face fewer issu
reimburs shift peer freseniu there
potenti investor concern ballot initi
facil staf requir state like california
think dialysi compani model alreadi account
on-going reimburs oper cost pressur
industri even though passag legisl
potenti financi effect difficult quantifi time
valuat growth profit feb
rais fair valu estim per share
incorpor sale medic group
busi model adjust growth
capit spend assumpt better-than-expect
sale price segment combin expect higher
return invest dialysi busi drive
remain rel unchang compani face
addit govern commerci reimburs
pressur long term assum major addit
consequ recent premium assist issu
multipl approxim enterpris
value/ebitda multipl
forecast averag annual growth
 dialysi servic segment incorpor
growth construct acquisit new clinic
model nearli averag growth revenu per
treatment larg driven
commerci insur payment rate dialysi
market expect larg portion clinic growth
occur intern market compani attempt
diversifi oper build oversea oper
scale anticip intern oper turn
profit
although oper margin dip
reimburs pressur chang retir plan
account expect margin gradual recov
longer term reimburs condit improv
cost-control intern scale help improv cost
structur forecast result oper margin nearli
return invest capit near
includ goodwil capit oper leas
estim cost capit
give medium uncertainti rate although
medicar
reimburs pressur consider headwind
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
share worth bear-cas scenario
believ earn narrow econom moat
economi scale larg network dialysi clinic
extens portfolio clinic affili
physician difficult smaller competitor replic
also probabl earn larger increment profit
smaller competitor central administr
oper bulk suppli agreement
oper approxim one third dialysi
clinic main competitor freseniu
medic form rel duopoli nearli
combin share dialysi market recent
began expand dialysi oper intern
market take consider time compani
amass signific share oper scale
think manag recent decis sell medic
group segment -- think possess materi
competit advantag middleman insur
servic provid -- net posit firm
think overal strength larg dialysi
manag like continu expand dialysi
market share scale acquisit smaller
competitor clinic particularli
market govern price pressur remain
futur profit compani broad low-cost
per share bull-cas scenario forecast
growth dialysi segment help growth
new clinic includ growth revenu per
treatment driven healthi commerci
payment lower-than-expect govern reimburs
pressur project nearli basi point oper
margin expans base-cas forecast less
reimburs pressur effect cost-control
measur greater contribut economi
scale scenario result return invest capit
rise near
bear case includ averag dialysi revenu
growth clinic growth neglig
revenu per treatment growth next five year
scenario assum worse-than-expect medicar
commerci payer reimburs pressur combin
oper margin lead oper margin
return capit near respect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oa global increas obes diabetes-rel
condit sustain strong demand dialysi
servic long term
larg dialysi oper help sustain low-
cost leadership help insul compani
reimburs pressur affect whole
intern expans remain earli
stage present attract growth
larg depend
commerci payer futur contract negoti
ofeder govern chang medicar state
budget constraint medicaid keep dialysi
provid potenti increas critic pressur
regul insur compani
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
oper fairli high financi leverag
gross debt/ebitda typic time
similarli ebitda coverag interest expens
histor consist time firm stabl
volum trend support rel consist cash flow
reimburs pressur remain on-going concern
compani abil maintain stabl profit
billion sale legaci healthcar partner segment
improv firm balanc sheet portion
proce use pay debt fund
earmark share repurchas even though
anticip larg deal horizon healthcar
partner deal show potenti risk
acquisit pay dividend
give medium uncertainti rate although
medicar
reimburs pressur consider headwind
profit compani broad low-cost oper
help mitig overal risk govern commerci
insur reimburs pressur particularli
medicar depress margin inabl gain
suffici scale compani intern dialysi
oper repres largest risk view
commerci reimburs
growth addit chang bundl payment
compani benefit payer diversif
small grow dialysi oper
intern market govern probe
concern patient inappropri steer
fine could theoret aris use
third-parti premium assist exchange-bas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
patient think new rule like limit
futur use practic potenti settlement fine
would probabl rel immateri valuat
think oper risk disrupt technolog
pharmaceut advanc minor concern slow shift
toward home-bas dialysi potenti threat
clinic think clinic-bas hemodialysi remain
high demand due sever ill patient
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
share
fund
share
fund
manag histor follow prudent capital-alloc
practic opinion healthcar partner merger
rais red flag manag strong execut
dialysi segment upheld overal posit compani
perform wed rather see manag deploy
capit strengthen firm competit advantag
global dialysi market manag disciplin
strategi expand larg dialysi clinic portfolio
remain prudent use capit view
healthcar partner merger significantli outsid
manag area expertis opportun
cost revenu synergi perspect although
perform segment depress return
capit led impair billion sale
busi unit favor outcom
sharehold opinion
kent thiri ceo sinc octob
juli thiri step ceo struggl
healthcar partner divis javier rodriguez becam
ceo dialysi oper rodriguez arriv
extens execut experi
compani robert lang join ceo
hilger cfo march hilger interim cfo
sinc march remain compani chief
account offic peform based-metr make
long-term incent plan execut
includ patient health measur oper incom
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
issu
maintain outlook reimburs
dont anticip dramat chang fair valu
estim compani fourth-quart
performancewhich includ medic group
busi discontinu operationsand outlook
continu mostli track expect result
show return normal oper condit
hurricane-rel
manag maintain billion billion
oper incom goal close
forecast manag capit spend outlook
nearli million year bit
expect continu like manag decis
sell medic group busi proce
repay acquisit wed remain somewhat
skeptic asset purchas outsid core dialysi
oper dont envis larg transact
would shift view firm narrow moat
continu oper quarter post
treatment growth adjust
oper margin rel unchang -- basi
point last year compani recogn
small non-cash impair relat outlook asia-
pacif region joint ventur mostli eras previou
gain recogn partnership despit benefit
lower epogen cost still envis slight margin
pressur year given on-going reimburs
pressur particularli flat medicar reimburs
growth combin higher labor cost previous
announc chang retir plan account
still see reimburs pressur persist weight
profit anticip favor payment
year base
pressur patient assist issu abat
medicar
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
